Upstream Bio Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Upstream Bio is a mid-sized biotechnology research company based in Waltham, Massachusetts. It is advancing verekitug, a clinical-stage monoclonal antibody that targets the receptor for thymic stromal lymphopoietin, an upstream driver of inflammatory signaling. The company aims to improve treatment options for millions of patients living with severe inflammatory diseases, with an initial focus on severe respiratory disorders. Operating in the biotechnology sector, it seeks to address immune-mediated conditions through upstream modulation of inflammation. In June 2026, the company announced its participation in the Goldman Sachs Global Healthcare Conference, highlighting continued engagement with the scientific and investment communities.